Subscribe
The exclusive manufacturing collaboration will establish production for adeno-associated virus gene-therapy treatments incorporating REGENXBIO’s NAV Technology.
Genzyme Announces $845-Million Gene Therapy Deal
AstraZeneca Signs on for CRISPR Gene Editing Technology
259 Prospect Plains Rd, Bldg H Cranbury, NJ 08512
609-716-7777